AVTX vs CF · P/E 0.0, rev $441.0K vs P/E 12, rev $5.94B
Avalo Therapeutics Inc (AVTX) versus CF Industries Holdings Inc (CF) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Not investment advice. Open the AVTX and CF stock pages for the full models.
Not investment advice.